X-154420732-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000116.5(TAFAZZIN):c.774G>A(p.Ser258Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,208,919 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000011 ( 0 hom. 2 hem. )
Consequence
TAFAZZIN
NM_000116.5 synonymous
NM_000116.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.11
Genes affected
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-154420732-G-A is Benign according to our data. Variant chrX-154420732-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 531187.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-154420732-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.11 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAFAZZIN | NM_000116.5 | c.774G>A | p.Ser258Ser | synonymous_variant | 10/11 | ENST00000601016.6 | NP_000107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAFAZZIN | ENST00000601016.6 | c.774G>A | p.Ser258Ser | synonymous_variant | 10/11 | 1 | NM_000116.5 | ENSP00000469981.1 |
Frequencies
GnomAD3 genomes AF: 0.00000902 AC: 1AN: 110875Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33089
GnomAD3 genomes
AF:
AC:
1
AN:
110875
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33089
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183390Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67850
GnomAD3 exomes
AF:
AC:
2
AN:
183390
Hom.:
AF XY:
AC XY:
1
AN XY:
67850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 12AN: 1098044Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 2AN XY: 363400
GnomAD4 exome
AF:
AC:
12
AN:
1098044
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
363400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000902 AC: 1AN: 110875Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33089
GnomAD4 genome
AF:
AC:
1
AN:
110875
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33089
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
3-Methylglutaconic aciduria type 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at